- Win
- 47.1%
- ▼2.9 vs Mid
- LP a game
- +0.60
- ±1.80
- Games
- 463
- a win +20.3 · a loss −17.4
- Pick · Ban
- 0.20 · 6.4%
- as Mid · any role
Teemo Mid on JP, last 14 days: Statikk Shiv, Liandry's Torment, Malignance; Press the Attack + Resolve; skill order E > Q > W (each the most played of 463 games).
Low sample. 463 games, fewer than 1,000. Read these numbers as rough.
Build
Start
Hp
×262% · 46.3% won
Spells
Ig
66% · 46.1% won
Skills
59% · 45.3% won
Items 40.0% of games with a core
- Statikk Shiv
- Liandry's Torment
- Malignance
- Sh
61.6%won55% · 27pick, 27 games - Rd
58.3%won18% · 9pick, 9 games
- Rd
62.4%won47% · 18pick, 18 games
57.0% won (47.2–66.3) · 100 games
4th: of the 49 games with this core that reached it · 5th: all builds. Win rates there are pulled toward the champion's rate at the slot, because a few games say little.
Skill path 49% of games · 46.1% won
| Ability | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2 | 8 | 10 | 12 | 13 | ||||||||||||||
| WW | 3 | 14 | 15 | 17 | 18 | |||||||||||||
| EE | 1 | 4 | 5 | 7 | 9 | |||||||||||||
| RR | 6 | 11 | 16 |
Core items
- Statikk Shiv › Liandry's Torment › Malignance40%57.0%47% to 66%
Skills
- ››starts E Q W59%45.3%267
- ››starts E Q WFew games10%52.2%46
- ››starts E Q EFew games9.0%43.9%41
Starting items
- Doran's Bow + 2 × Health Potion 22%47.1% won
- Dark Seal + Refillable Potion Few games4.5%52.4% won
Boots
- Immortal Path Few games15%57.8% won
- Swiftmarch Few games14%45.3% won
Summoner spells
- Flash + Teleport 25%49.6% won
Every option as a table26 options
| Option | Pick | Win | 95% range | Games |
|---|---|---|---|---|
| Core items | ||||
| Statikk Shiv › Liandry's Torment › Malignance | 40% | 57.0% | 47.2%–66.3% | 100 |
| 4th item, of 120 games that reached it | ||||
| ShadowflameFew games | 30% | 66.7% | 50.3%–79.8% | 36 |
| Rabadon's DeathcapFew games | 18% | 52.4% | 32.4%–71.7% | 21 |
| Boots | ||||
| Spellslinger's Shoes | 41% | 46.0% | 39.1%–53.2% | 189 |
| Immortal PathFew games | 15% | 57.8% | 46.2%–68.6% | 71 |
| SwiftmarchFew games | 14% | 45.3% | 33.7%–57.4% | 64 |
| No bootsFew games | 8.4% | 33.3% | 20.6%–49.0% | 39 |
| Chainlaced CrushersFew games | 5.8% | 51.9% | 34.0%–69.3% | 27 |
| Starting items | ||||
| Doran's Ring + 2 × Health Potion | 62% | 46.3% | 40.6%–52.1% | 285 |
| Doran's Bow + 2 × Health Potion | 22% | 47.1% | 37.7%–56.7% | 102 |
| Dark Seal + Refillable PotionFew games | 4.5% | 52.4% | 32.4%–71.7% | 21 |
| Summoner spells | ||||
| Flash + Ignite | 66% | 46.1% | 40.5%–51.7% | 304 |
| Flash + Teleport | 25% | 49.6% | 40.7%–58.5% | 117 |
| Skill order | ||||
| Max E Q W · starts E Q W | 59% | 45.3% | 39.5%–51.3% | 267 |
| Max E W Q · starts E Q WFew games | 10% | 52.2% | 38.1%–65.9% | 46 |
| Max E Q W · starts E Q EFew games | 9.0% | 43.9% | 29.9%–59.0% | 41 |
| First 11 skill points | ||||
| E Q W E E R E Q E Q R | 49% | 46.1% | 39.6%–52.7% | 217 |
| E Q E W E R E Q E Q RFew games | 7.7% | 47.1% | 31.5%–63.3% | 34 |
| E Q W E E R E W E W RFew games | 6.3% | 46.4% | 29.5%–64.2% | 28 |
| Finished items | ||||
| Shadowflame | 22% | 54.4% | 44.8%–63.7% | 103 |
| Rabadon's DeathcapFew games | 11% | 59.6% | 46.1%–71.8% | 52 |
| Nashor's ToothFew games | 9.1% | 52.4% | 37.7%–66.6% | 42 |
| Blackfire TorchFew games | 7.8% | 52.8% | 37.0%–68.0% | 36 |
| HeartsteelFew games | 6.7% | 51.6% | 34.8%–68.0% | 31 |
| Gunmetal GreavesFew games | 5.4% | 44.0% | 26.7%–62.9% | 25 |
| Dusk and DawnFew games | 5.2% | 41.7% | 24.5%–61.2% | 24 |
Questions
What do Teemo Mid players build first on JP?
The most played core is Statikk Shiv, then Liandry's Torment, then Malignance: 22% of 463 games in all ranks, last 14 days, 57.0% win rate.
What skill order do Teemo Mid players use?
Most often they max E, Q, W and start E, Q, W: 59% of 455 games with a skill order in all ranks, last 14 days, 45.3% win rate.
Which summoner spells do Teemo Mid players take?
Flash and Ignite, in 66% of 463 games in all ranks, last 14 days, 46.1% win rate.









































